SOLID TUMOR, KRAS MUTATION

Clinical trials for SOLID TUMOR, KRAS MUTATION explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMOR, KRAS MUTATION trials appear

Sign up with your email to follow new studies for SOLID TUMOR, KRAS MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

First patients test new pill targeting tough stomach cancers

Disease control Completed

This was a first-in-human study to find a safe and tolerable dose of a new oral drug, BI 3706674, for adults with advanced stomach or esophageal cancer that had stopped responding to other treatments. The trial tested different dose levels to see how the drug was processed by the…

Matched conditions: SOLID TUMOR, KRAS MUTATION

Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

SOLID TUMOR, KRAS MUTATION

Get alerted when new SOLID TUMOR, KRAS MUTATION trials appear

First patients test new pill targeting tough stomach cancers